Concepedia

Publication | Closed Access

A phase I dose escalation study of epidermal growth factor receptor (EGFR) tyrosine kinase (TK) inhibitor CP-358,774 in patients (pts) with advanced solid tumors

DOI

58

Citations

0

References

2000

Year

Daniel D. Karp, Karen J. Ferrante, Thomas G. Tensfeldt, Robert L. Thurer, Joseph LoCicero, Mark S. Huberman, Francesca Wirth, Richard Hellman, Patrick Poulin, Sandra Silberman,
Lung Cancer

No additional data available for this publication yet. Check back later!